Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.64 |
| ▸ | NCEH1 | Q6PIU2 | 6/20 | 0.56 |
| ▸ | NQO1 | P15559 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.51 |
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.49 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.49 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21331556 | 0.90 | MAPT (0.58) | MAPTNCEH1NQO1SMN1; SMN2NPC1 | |
| SCHEMBL7380732 | 0.80 | SMN1; SMN2 (0.56) | MAPTNCEH1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL29937151 | 0.80 | SMN1; SMN2 (0.56) | MAPTNCEH1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL13391169 | 0.79 | MAPT (0.58) | MAPTNCEH1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL26622001 | 0.79 | RAB9A (0.55) | MAPTNCEH1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL29428410 | 0.78 | MAPT (1.00) | MAPTNQO1SMN1; SMN2RAB9AHPGD | |
| SCHEMBL31553099 | 0.78 | CYP19A1 (0.51) | MAPTNCEH1NQO1SMN1; SMN2POLB | |
| SCHEMBL998182 | 0.78 | MAPT (1.00) | MAPTNQO1SMN1; SMN2RAB9AHPGD | |
| SCHEMBL28862956 | 0.78 | RXFP1 (0.44) | MAPTNCEH1NQO1SMN1; SMN2KDM4E | |
| SCHEMBL17086891 | 0.77 | CYP19A1 (0.45) | MAPTNQO1CYP19A1CYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 316 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109305981-B | Synthesis method of 2-hydroxynaphthalene-1-boric acid | 白银棓诺新材料有限公司 | 2021-10-29 | — | — | CN | claimed |
| CN-109305981-A | The synthetic method of 2 hydroxy naphthalene -1- boric acid | 白银棓诺新材料有限公司 | 2019-02-05 | — | — | CN | claimed |
| CN-104507913-A | Antiproliferative benzo[b]azepin-2-ones | HOFFMANN LA ROCHE | 2015-04-08 | — | — | CN | claimed |
| CN-104470940-A | 2-oxo-2,3,4,5-tetrahydro-1 h-benzo[b]diazepines and their use in the treatment of cancer | HOFFMANN LA ROCHE | 2015-03-25 | — | — | CN | claimed |
| CN-104470905-A | Substituted hetero-azepinones | HOFFMANN LA ROCHE | 2015-03-25 | — | — | CN | claimed |
| CN-104418716-A | Preparation method of nabumetone intermediate 2-methoxyl-6-naphthaldehyde | FUJIAN LIFEIKE BIOTECHNOLOGY CO LTD | 2015-03-18 | — | — | CN | claimed |
| WO-1998050334-A1 | PRODUCTION OF BROMINATED METHOXYNAPHTHALENE COMPOUNDS | ALBEMARLE CORPORATION (US) | 1998-11-12 | — | — | WO | claimed |
| JP-62142138-A | — | — | None | — | — | JP | disclosed |
| JP-10139712-A | — | — | None | — | — | JP | disclosed |
| US-20260123269-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2026-04-30 | — | — | US | disclosed |
| US-12581850-B2 | Organic electroluminescence element, composition, powder, electronic equipment, and novel compound | IDEMITSU KOSAN CO., LTD. (JP) | 2026-03-17 | — | — | US | disclosed |
| US-20260060000-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2026-02-26 | — | — | US | disclosed |
| US-20250386661-A1 | LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE ORGANOMETALLIC COMPOUND | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-12-18 | — | — | US | disclosed |
| EP-0163338-B1 | PROCESS FOR PREPARING NAPROXEN | Nobel Chemicals AB (SE) | 1987-09-09 | — | — | EP | disclosed |
| JP-S62142138-A | PRODUCTION OF 2-6-METHOXY-2-NAPHTHYL PROPIONIC ACID | SANWA KAGAKU KENKYUSHO:KK | 1987-06-25 | — | — | JP | disclosed |
| EP-0221677-A2 | p-Aminophenols, derivatives thereof and use for manufacture of a medicament | E.R. Squibb & Sons, Inc. (US) | 1987-05-13 | — | — | EP | disclosed |
| EP-0163338-A1 | Process for preparing naproxen | Nobel Chemicals AB (SE) | 1985-12-04 | — | — | EP | disclosed |
| US-4423244-A | Process for the preparation of the d-2-(6-methoxy-2-naphthyl)-propionic acid | ALFA CHEMICALS ITALIANA S.P.A. (IT) | 1983-12-27 | — | — | US | disclosed |
| US-3994968-A | 2-(5'-Halo-6'-methoxynaphth-2'-yl)-acrylic acid | SYNTEX CORPORATION (PM) | 1976-11-30 | — | — | US | disclosed |
| US-3960957-A | 2-(6'-methoxynaphth-2'yl) propionaldoxime and 5'-halo derivatives thereof | SYNTEX CORPORATION (PM) | 1976-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260123269-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, LDLR, MLX | MAPT 3924/4885NCEH1 2110/4885NQO1 978/4885 |
| US-20260060000-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | RER1, RIF1, RPS19 | MAPT 4037/4885NCEH1 3318/4885NQO1 1286/4885 |
| US-12581850-B2 | Organic electroluminescence element, composition, powder, electronic equipment, and novel compound | SCO2, SOD1, ITGA1 | MAPT 2934/4885NCEH1 2925/4885NQO1 1396/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.